Posaconazole Tablets Suppliers & Bulk Manufacturers

Available Forms: Delayed-Release Tablets

Available Strengths: 300 mg

Reference Brands: Noxafil(US & EU)

Category: Anti-fungal

Posaconazole Tablets is available in Delayed-Release Tablets and strengths such as 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Posaconazole Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Posaconazole Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Posaconazole delayed-release tablets are approved in the EU and US for prophylaxis and treatment of invasive fungal infections. In the EU, MSD’s Noxafil is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on comprehensive clinical data, biosimilarity assessments, and ongoing pharmacovigilance. Both regions require detailed regulatory dossiers for initial approval and continuous safety monitoring. For expert assistance with dossiers, regulatory submissions, and compliance, visit PharmaTradz, your trusted partner in pharmaceutical regulatory solutions. We facilitate efficient market access for posaconazole delayed-release tablets, ensuring adherence to European and American standards for safe, effective antifungal therapy.